Sfoglia per RIVISTA
AMERICAN JOURNAL OF HEMATOLOGY
Collezione AOU Novara

  

Items : 11

Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real-World" study. in American journal of hematology / Am J Hematol. 2023 Feb;98(2):E24-E27. doi: 10.1002/ajh.26779. Epub 2022 Nov 25.

2023
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara

Levi S; Trentin L; Foà R; Cuneo A; Herishanu Y; Gentile M; Perry C; Gattei V; Gaidano G; Rossi D; Neri A; Olivieri J; Bomben R; Zucchetto A; Visentin A; Loseto G; Pietrasanta D; Chiarenza A; Braester A; Murru R; Aviv A; Varettoni M; Coscia M; Tadmor T; Shvidel L; Sportoletti P; Laurenti L; Reda G; Ruchlemer R; et alii...

The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL. in American journal of hematology / Am J Hematol. 2023 Dec;98(12):1856-1868. doi: 10.1002/ajh.27093. Epub 2023 Sep 29.

2023
AOU Novara
AO Alessandria
AOU Città della Salute di Torino

Stamatopoulos K; Ghia P; Trentin L; Stavroyianni N; Vandenberghe E; Iyengar S; Coscia M; Rambaldi A; Montserrat E; Cuneo A; Vitale C; Segundo LYS; Pocali B; Yassin M; Wróbel T; Wasik-Szczepanek E; Van Der Spek E; van Gelder M; van Kampen R; Tonino SH; Te Raa D; Shrestha A; Saghumyan G; Mirás F; Reda G; Karlsson LK; Milosevic I; Del Poeta G; Gutwein O; et alii...

Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts. in American journal of hematology / Am J Hematol. 2023 Aug;98(8):E204-E208. doi: 10.1002/ajh.26960. Epub 2023 May 24.

2023
ASL Città di Torino
ASL Torino 4
AO Cuneo
ASL Biella
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara
AO Alessandria

Della Porta MG; Pasini P; Naldi I; Finelli C; Giordano L; Turrini M; Tanasi I; Tosi P; Selleri C; Marchetti M; Norata M; Frigeni M; Sancetta R; Fianchi L; Galimberti S; Grimaldi D; Ferrara F; Castelli A; Di Veroli A; Di Bona E; Calvisi A; Rivoli G; Bono R; Nicolino B; Occhini U; Molteni A; Guarini A; Genua A; Diral E; et alii...

Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model. in American journal of hematology / Am J Hematol. 2022 May;97(5):E176-E180. doi: 10.1002/ajh.26502. Epub 2022 Feb 25.

2022
AO Cuneo
ASL Cuneo 1
AOU Città della Salute di Torino
AOU Novara

Mauro FR; Trentin L; Foa' R; Tedeschi A; Gaidano G; Cuneo A; Coscia M; Guarente V; Noto A; Ielo C; Deodato M; Del Poeta G; Stelitano C; Moia R; Giordano A; Levato L; Rigolin GM; Gentile M; Murru R; De Paoli L; Laurenti L; Vitale C; Ciolli S; Chiarenza A; Sportoletti P; Frustaci AM; Visentin A; Reda G; Giannarelli D; et alii...

Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19. in American journal of hematology / Am J Hematol. 2022 Dec;97(12):E470-E473. doi: 10.1002/ajh.26732. Epub 2022 Sep 27.

2022
AOU Città della Salute di Torino
AOU Novara
AO Alessandria

Vannucchi AM; Rambaldi A; Curto-Garcia N; Cavalca F; Bellini M; Betti S; Borsani O; de Na??cz AK; Cattaneo D; Bucelli C; Cichocka E; Koschmieder S; Lopez Abadia E; Kusec R; Xicoy Cirici B; Angona A; Navas Elorza B; Sagues Serrano M; Carreno-Tarragona G; Osorio S; Carli G; Hernandez-Boluda JC; Garcia-Gutierrez V; Marin Sanchez A; Magro Mazo E; Griesshammer M; Quiroz Cervantes K; Bolaños Calderón E; Patriarca A; et alii...

Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study. in American journal of hematology / Am J Hematol. 2021 May 1;96(5):E168-E171. doi: 10.1002/ajh.26127. Epub 2021 Feb 24.

2021
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara

Gentile M; Gattei V; Foà R; Ferrarini M; Polliack A; Gaidano G; Trentin L; Cuneo A; Fronza G; Cutrona G; Rossi D; Di Raimondo F; Neri A; Bomben R; Biagi A; Del Giudice I; Angeletti I; Galimberti S; Rago A; Caracciolo D; Cassin R; D'Arrigo G; Mendicino F; Botta C; Martino EA; Vigna E; Zucchetto A; Rossi FM; Scortechini I; et alii...

Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials. in American journal of hematology / Am J Hematol. 2021 Aug 1;96(8):E269-E272. doi: 10.1002/ajh.26201. Epub 2021 May 3.

2021
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara

D Arrigo G; Murru R; Gentile M; Gattei V; Polliack A; Trentin L; Gaidano G; Di Raimondo F; Cuneo A; Cutrona G; Rossi D; Menichini P; Olivieri J; Fronza G; Monti P; Del Giudice I; Bomben R; Neri A; Angeletti I; Biagi A; Rago A; Martino EA; Cassin R; Galimberti S; Foà R; Ferrarini M; Scortechini I; Rossi FM; Zucchetto A; et alii...

TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases. in American journal of hematology / Am J Hematol. 2021 Aug 1;96(8):E306-E310. doi: 10.1002/ajh.26235. Epub 2021 May 25.

2021
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara

Gentile M; Gattei V; Ferrarini M; Foà R; Polliack A; Trentin L; Cuneo A; Gaidano G; Di Raimondo F; Rossi D; Olivieri J; Jaksic O; Bomben R; Neri A; Fronza G; Rago A; Angeletti I; Cutrona G; Del Giudice I; Biagi A; Galimberti S; D'Arrigo G; Al-Janazreh H; Martino EA; Vigna E; Tripepi G; Zucchetto A; Rossi FM; Recchia AG; et alii...

Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases. in American journal of hematology / Am J Hematol. 2018 Sep;93(9):E216-E219. doi: 10.1002/ajh.25206. Epub 2018 Jul 30.

2018
AOU Novara

Morabito F; Shanafelt TD; Gentile M; Reda G; Mauro FR; Rossi D; Di Renzo N; Molica S; Angrilli F; Chiarenza A; Cutrona G; Chaffee KG; Parikh SA; Tripepi G; D'Arrigo G; Vigna E; Recchia AG; Cortelezzi A; Gaidano G; Di Raimondo F; Fais F; Foà R; Neri A; Ferrarini M;

Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease. in American journal of hematology / Am J Hematol. 2016 Oct;91(10):995-1001. doi: 10.1002/ajh.24463. Epub 2016 Jul 14.

2016
AOU Città della Salute di Torino
AOU Novara

Forghieri F; Cascavilla N; Rambaldi A; Scaramucci L; Ruggeri M; Rodeghiero F; Bergamaschi M; Vincelli ID; Di Giacomo V; Simula MP; Carpenedo M; Borchiellini A; Cottone F; Santoro C; Gaidano G; Fazi P; Mandelli F; Efficace F; Petrungaro A; Ditonno P; Caocci G; Cirrincione S; Mazzucconi MG;

Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia. in American journal of hematology / Am J Hematol. 2016 Jun;91(6):617-22. doi: 10.1002/ajh.24362. Epub 2016 Apr 24.

2016
AOU San Luigi di Orbassano
AOU Novara

Pane F; Martinelli G; Alimena G; Cavo M; Soverini S; Venturi C; Levato L; Musolino C; Pia Falcone A; Lunghi M; Tiribelli M; Cavazzini F; Bocchia M; D'Adda M; Luciano L; Stagno F; Albano F; Martino B; Abruzzese E; Rege-Cambrin G; Usala E; Carella AM; Gozzini A; Breccia M; Castagnetti F; Gugliotta G; Saglio G; Rosti G; Baccarani M; et alii...